Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
45.98
-0.68 (-1.46%)
At close: Feb 13, 2026, 4:00 PM EST
46.00
+0.02 (0.04%)
After-hours: Feb 13, 2026, 7:35 PM EST
Scholar Rock Holding Market Cap
Scholar Rock Holding has a market cap or net worth of $4.69 billion as of February 13, 2026. Its market cap has increased by 24.02% in one year.
Market Cap
4.69B
Enterprise Value
4.43B
1-Year Change
24.02%
Ranking
Category
Stock Price
$45.98
Market Cap Chart
Since May 24, 2018, Scholar Rock Holding's market cap has increased from $378.83M to $4.69B, an increase of 1,138.11%. That is a compound annual growth rate of 38.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 4.69B | 4.38% |
| Dec 31, 2025 | 4.49B | 11.06% |
| Dec 31, 2024 | 4.05B | 198.32% |
| Dec 29, 2023 | 1.36B | 190.08% |
| Dec 30, 2022 | 467.55M | -46.39% |
| Dec 31, 2021 | 872.09M | -46.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunovant | 5.29B |
| Protagonist Therapeutics | 5.12B |
| Structure Therapeutics | 4.96B |
| CRISPR Therapeutics AG | 4.95B |
| Celcuity | 4.82B |
| Apogee Therapeutics | 4.72B |
| Crinetics Pharmaceuticals | 4.54B |
| Amicus Therapeutics | 4.50B |